http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108157633-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2f7c1629d09127a6ae758aae1a268d8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K40-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K40-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-163
filingDate 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4827dcbe89f8a1b47b89425a114bf6e
publicationDate 2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108157633-A
titleOfInvention Pig starter feed microcapsules
abstract The invention belongs to field of fodder, and in particular to a kind of pig starter feed microcapsules, the core material of the microcapsules is lactic acid bacteria;Wall material is propylene glycol alginate;The core material of the microcapsules and the ratio of wall material are:0.05‑0.1:1.The preparation method of the microcapsules is:1) preparation of strain fermentating liquid;2) mass fraction is made as 30% 40% aqueous solution in wall material;3) high cut disperse emulsification is carried out after step 1) is mixed with the liquid of step 2), precursor liquid is made;4) solid-state microcapsule granule is made through vacuum atomizing drying in precursor liquid.Micro-encapsulated diet is added in the present invention, using lactic acid bacteria as core material, propylene glycol alginate is wall material;Propylene glycol alginate can be rapidly destroyed in animal intestinal tract, and the lactic acid bacteria of release can take up the field planting point in enteron aisle, and proliferation becomes dominant microflora rapidly, so as to reach the effects that inhibiting growth of pathogenic bacteria.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109527238-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110754580-A
priorityDate 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID182655
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3847
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3885
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID182655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443753
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131752735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448013983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447773061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3885

Total number of triples: 45.